아시아 태평양 척수 손상 치료 시장, 유형별(비수술적 관리 및 수술적 관리), 손상 유형(완전 척수 손상 및 부분 척수 손상), 손상 수준(경추 척수 손상, 흉추 척수 손상, 요추 척수 손상 및 천추 척수 손상), 성별(남성 및 여성), 최종 사용자(병원, 외상 센터, 전문 클리닉, 클리닉, 외래 및 연구 센터 등) - 2032년까지의 산업 동향 및 전망
아시아 태평양 척수 손상 치료 시장 분석
2021년 5월 국제 보건 정책 및 관리 저널(International Journal of Health Policy and Management)에 게재된 논문에 따르면, 척수 손상(SCI) 건강 연구 분야에서 파트너십 접근 방식이 점점 더 인기를 얻고 있으며, SCI 연구 파트너십 챔피언들의 성공을 탐구하고 배울 수 있는 기회가 창출되고 있습니다. 아시아 태평양 척수 손상 치료 시장에서 협력과 파트너십 확대가 확대되는 것은 혁신을 촉진하고, 연구를 발전시키며, 환자 치료를 개선하는 데 매우 중요합니다. 다양한 분야의 전문 지식을 결합함으로써 이러한 협력은 새로운 치료법 개발을 촉진하고, 재활 기술을 향상시키며, 의료 기기를 개선합니다.
아시아 태평양 척수 손상 치료 시장 규모
아시아 태평양 척수 손상 치료 시장은 2024년 16억 1천만 달러에서 2032년 26억 1천만 달러로 성장할 것으로 예상되며, 2025년에서 2032년까지의 예측 기간 동안 6.3%의 CAGR로 성장할 것입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 적용 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 수입 수출 분석, 생산 능력 개요, 생산 소비 분석, 가격 추세 분석, 기후 변화 시나리오, 공급망 분석, 가치 사슬 분석, 원자재/소모품 개요, 공급업체 선택 기준, PESTLE 분석, Porter 분석 및 규제 프레임워크가 포함됩니다.
아시아 태평양 척수 손상 치료 시장 동향
“협력 확대 및 파트너십 확대”
척수 손상(SCI) 연구 분야가 발전함에 따라, 학술 기관, 연구 기관, 제약 회사, 의료 기기 제조업체 간의 협력이 증가하고 있다는 점이 주목할 만한 추세입니다. 이러한 제휴는 제한된 재생 능력과 복잡한 치료 과정 등 SCI의 고유한 과제를 해결하기 위한 전문 지식, 자원, 그리고 자금의 공유를 촉진합니다. 다양한 강점을 결합함으로써 이러한 파트너십은 줄기세포 치료, 신경보철, 유전자 치료 등 혁신적인 치료법 개발을 가속화하고 있습니다. 또한, 업계 이해관계자들은 재활 프로그램 강화, 이동 보조기구 개선, 그리고 진단 도구 개선을 위해 힘을 합치고 있습니다. 새롭게 떠오르는 추세는 임상 데이터의 공동 공유로, SCI의 병태생리에 대한 이해를 심화하고 개인 맞춤형 치료 전략을 수립하는 데 도움이 됩니다. 또한, 아시아 태평양 지역 의료 서비스 제공자와 정책 입안자 간의 협력은 최첨단 치료법의 접근성을 높이고 치료비를 절감하는 개혁을 주도하고 있습니다. 전반적으로 이러한 협력 추세는 치료 기준을 높일 뿐만 아니라 척수 손상 치료를 위한 전 세계적인 노력을 촉진하여 궁극적으로 환자의 삶을 변화시킵니다.
보고서 범위 및 아시아 태평양 척수 손상 치료 시장 세분화
|
속성 |
아시아 태평양 척수 손상 치료 시장 통찰력 |
|
다루는 세그먼트 |
|
|
적용 지역 |
중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀 및 아시아 태평양의 나머지 지역 |
|
주요 시장 참여자 |
Novartis AG(스위스), Pfizer Inc.(미국), Medtronic(아일랜드), Zimmer Biomet(미국), Abbott(미국), Amneal Pharmaceuticals LLC(미국), Sanofi(프랑스), Axonis Therapeutics(미국), Zydus Group(인도), Lineage Cell Therapeutics, Inc.(미국), Sun Pharmaceutical Industries Ltd.(인도), Camber Pharmaceuticals, Inc.(미국), Dr. Reddy's Laboratories Ltd.(인도), Teva Pharmaceuticals US, Inc.(이스라엘), Niksan Pharmaceuticals(인도), Covis Pharma GmbH(스위스), Indian Spinal Injuries Centre(인도), Jubilant Cadista Pharmaceuticals Inc.(미국), Johnson & Johnson(미국), Nervgen Pharma Corp(캐나다), Advacare Pharma(미국), Boston Scientific(미국), Vasudha Pharma(인도), Enomark(인도), Glenmark Pharmaceuticals US Inc.(미국), Inova Pharmaceuticals(호주), Globus Medical(미국), Zimvie Inc.(미국), Bioaxone(캐나다) |
|
시장 기회 |
|
|
부가가치 데이터 정보 세트 |
Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 적용 범위, 주요 업체 등 시장 시나리오에 대한 통찰력 외에도 수입 수출 분석, 생산 능력 개요, 생산 소비 분석, 가격 추세 분석, 기후 변화 시나리오, 공급망 분석, 가치 사슬 분석, 원자재/소모품 개요, 공급업체 선택 기준, PESTLE 분석, Porter 분석 및 규제 프레임워크가 포함됩니다. |
아시아 태평양 척수 손상 치료 시장 정의
척수 치료는 척수에 영향을 미치는 손상, 질병 또는 장애를 관리하기 위한 다양한 의학적 접근법을 포함합니다. 중증도와 상태에 따라 진통제, 항염증제, 근이완제와 같은 약물 치료를 통해 증상을 완화할 수 있습니다. 감압술이나 척추 유합술과 같은 수술적 처치는 안정화 및 회복을 위해 필요할 수 있습니다. 물리 치료는 운동 능력 회복과 근육 강화에 도움이 되며, 재활 치료는 일상생활과 자립을 지원합니다. 휠체어나 보조기와 같은 보조 장치는 이동을 돕고, 줄기세포 치료와 같은 새로운 치료법은 잠재적인 재생 효과를 제공합니다. 심리적 지원과 침술, 수치료와 같은 대체 요법 또한 회복을 촉진할 수 있습니다. 더 나은 결과를 위해서는 다학제적 접근과 조기 개입이 매우 중요합니다.
아시아 태평양 척수 손상 치료 시장 동향
운전자
- 협력 확대 및 파트너십 확대
척수 손상 연구가 지속적으로 발전함에 따라 학술 기관, 연구 기관, 제약 회사, 의료기기 제조업체 간의 협력이 점점 더 중요해지고 있습니다. 이러한 파트너십을 통해 제한된 재생 가능성과 복잡한 치료 과정 등 척수 손상과 관련된 심각한 난관을 극복하기 위한 전문 지식, 자원, 그리고 자금의 공동 활용이 가능해졌습니다. 협력을 통해 줄기세포 치료, 신경보철, 유전자 치료와 같은 혁신적인 치료법 개발이 가속화되었습니다. 또한, 업계 관계자들은 더욱 효과적인 재활 프로그램을 개발하고, 이동 보조기구와 같은 의료 기기를 개선하며, 더 나은 진단 도구를 개발하기 위해 협력하고 있습니다. 파트너십 확대는 임상 데이터 공유 플랫폼을 제공하는데, 이는 척수 손상의 병태생리에 대한 이해를 높이고 개인 맞춤형 치료 전략을 최적화하는 데 필수적입니다. 또한, 글로벌 의료 서비스 제공자와 정책 입안자 간의 협력은 의료 개혁을 추진하고, 최첨단 치료법에 대한 접근성을 향상시키며, 척수 손상 치료법의 적정 가격을 보장하는 데 도움이 됩니다. 궁극적으로, 이러한 성장하는 파트너십은 치료의 질을 향상시킬 뿐만 아니라 척수 손상에 대한 치료법을 찾기 위한 글로벌 노력에 기여하고, 혁신을 주도하며, 전 세계적으로 SCI의 영향을 받는 사람들의 삶을 개선합니다.
예를 들어,
- 2021년 5월, International Journal of Health Policy and Management에 게재된 기사에 따르면, 척추 손상(SCI) 건강 연구 분야에서 파트너십 접근 방식이 점점 더 인기를 얻고 있으며, SCI 연구 파트너십 챔피언의 성공을 탐색하고 이를 통해 배울 수 있는 기회가 생겨나고 있습니다.
- 2023년 5월, TechTarget Network에 게재된 기사에 따르면, 리브 재단과 앨버타 대학교의 파트너십은 척수 손상 연구 분야의 오픈 데이터 공유를 촉진하여 가치, 지식 공유, 그리고 데이터 투명성을 증진하는 것을 목표로 했습니다. 앨버타 대학교와 리브 재단은 척수 손상 오픈 데이터 커먼즈(ODC-SCI)를 통해 오픈 데이터 공유를 촉진하는 3개년 공동 프로젝트를 시작했습니다.
- 전 세계 척수 손상 치료 시장에서 협력과 파트너십 확대는 혁신을 주도하고, 연구를 발전시키며, 환자 치료를 개선하는 데 매우 중요합니다. 다양한 분야의 전문 지식을 결합함으로써 이러한 협력은 새로운 치료법 개발을 촉진하고, 재활 기술을 향상시키며, 의료 기기를 개선합니다. 결과적으로 척수 손상 환자들은 더욱 효과적이고 개인 맞춤형 치료와 더 나은 치료 결과의 혜택을 누리게 됩니다. 파트너십에 대한 지속적인 투자를 통해 시장은 척수 손상 치료 및 잠재적 완치법 모두에서 상당한 진전을 이루어 궁극적으로 전 세계 수백만 명의 삶의 질을 향상시킬 준비가 되어 있습니다.
치료 방법의 기술적 발전
줄기세포 치료, 신경보철, 첨단 신경자극 기술과 같은 혁신은 척수 손상 환자의 회복 가능성을 크게 향상시키고 있습니다. 로봇 외골격과 인공지능을 활용한 맞춤형 치료 계획은 재활 치료 결과를 향상시킵니다. 또한, 척수 재생용 생체재료와 CRISPR와 같은 유전자 편집 기술의 획기적인 발전은 손상된 기능 회복에 대한 새로운 희망을 제시합니다. 이러한 최첨단 치료법은 치료 효과를 높일 뿐만 아니라, 삶의 질 향상을 위한 첨단 솔루션을 찾는 환자가 증가함에 따라 시장 규모를 확대하고 있습니다.
예를 들어,
- 2023년 10월, NCBI에 발표된 논문에 따르면, 하이드로젤과 같은 유연한 생체재료 개발과 같은 척수 손상(SCI) 치료의 기술적 발전이 조직 복구의 어려움을 해결하고 있습니다. 이러한 재료는 병변 형태에 적응하고, 섬유화를 예방하며, 축삭 성장을 촉진함으로써 척수 재생을 지원합니다.
- 2021년 7월, NCBI에 발표된 논문에 따르면 경막외 전기 자극(EES)과 같은 척수 손상 치료의 기술적 발전이 전임상 및 임상 연구 모두에서 유망한 결과를 보였습니다. EES는 척수 손상 후 감각 및 운동 기능을 향상시켜 회복 결과 개선 가능성을 보여줍니다. 이러한 혁신은 척수 손상 재활에서 전기 자극의 역할이 점차 커지고 있음을 보여줍니다.
- 기술 발전은 척수 손상 치료의 판도를 변화시키고 있으며, 환자에게 새로운 희망을 제공하고 회복 결과를 크게 향상시키고 있습니다. 줄기세포 치료, 신경보철, 신경자극, 그리고 인공지능을 활용한 맞춤형 치료의 혁신은 재활 치료의 가능성을 높이고 있습니다. 생체재료와 유전자 편집 기술의 획기적인 발전은 척수 재생의 경계를 더욱 넓혀 손상된 기능을 회복하고 삶의 질을 향상시키고 있습니다. 이러한 최첨단 치료법이 지속적으로 발전함에 따라 척수 손상 치료 시장은 성장하여 도움이 필요한 사람들에게 더욱 발전되고 효과적인 솔루션을 제공할 것으로 예상됩니다.
기회
- 증가하는 노인 인구
나이가 들면서 골밀도, 근력, 균형 감각이 저하되어 낙상 위험이 커지는데, 이는 척수 손상 인구에서 척수 손상의 주요 원인입니다. 이러한 인구학적 변화는 전문적인 치료와 재활 서비스를 필요로 하는 환자층의 증가로 이어집니다. 이러한 수요는 부상 후 즉각적인 치료뿐만 아니라 통증, 경직, 욕창 등 척수 손상 관련 합병증의 장기적인 관리에 대한 요구로 이어지고 있으며, 이러한 합병증은 지속적인 치료가 필요한 경우가 많습니다.
예를 들어,
- 2024년 1월, 인구조사국(Population Reference Bureau)이 발표한 자료에 따르면, 65세 이상 미국인의 수는 2022년 5,800만 명에서 2050년 8,200만 명으로 47% 증가할 것으로 예상되며, 전체 인구에서 65세 이상 인구가 차지하는 비중은 17%에서 23%로 증가할 것으로 예상됩니다. 척추 손상에 취약한 고령 인구 증가는 수요를 촉진하고 척추 손상 치료 시장을 확대할 것입니다.
- 2019년 10월, 미국 국립의학도서관(National Library of Medicine)에 발표된 논문에 따르면, 연구의 60%에서 기능 장애 수준, 기능적 어려움, 일상생활 동작, 그리고 신체 능력 등이 확인되었습니다. 이 연구는 노인에서 요통(LBP)의 높은 유병률과 기능 장애를 시사했습니다.
더욱이, 고령 인구는 척수 손상 치료에 있어 고유한 어려움을 겪는 경우가 많으며, 이는 맞춤형 접근법과 혁신적인 솔루션을 필요로 합니다. 고령자는 치료 계획을 복잡하게 만들고 전문적인 치료 전략을 필요로 하는 기존 질환을 가지고 있을 수 있습니다. 이러한 상황은 연령별 맞춤형 치료법 및 보조 기구 연구 개발의 필요성을 부추깁니다. 또한, 단순히 척수 손상의 신체적 측면을 다루는 것을 넘어 노인 환자의 정신 건강 지원, 사회 통합, 그리고 삶의 질 향상까지 아우르는 연구 개발에 중점을 두고 있습니다. 따라서 고령 인구 증가는 척수 손상 치료 시장의 성장과 다각화를 촉진하는 촉매제 역할을 하며, 이해관계자들이 혁신을 통해 고령자의 요구에 맞춘 포괄적인 치료 솔루션을 제공하도록 유도합니다.
- 외상성 부상 발생률 증가
교통사고, 낙상, 스포츠 부상, 폭력 등 외상성 손상은 전 세계 척수 손상(SCI) 치료 시장에 중요한 기회를 제공합니다. 이러한 사고의 빈도가 증가함에 따라 척수 손상 환자 수도 증가하여 잠재적인 치료 대상 환자층이 확대되고 있습니다. 이러한 추세는 특히 고위험 활동에 더 많이 참여하는 젊은층에서 두드러집니다. 응급 치료, 수술적 중재, 재활 서비스, 보조 기술 등 효과적이고 진보된 치료 옵션에 대한 수요 증가는 SCI 치료 시장의 성장을 촉진합니다. 의료기기 제조업체, 제약 회사, 그리고 의료 서비스 제공업체는 외상성 SCI 환자의 요구에 맞춘 혁신적인 치료법과 서비스를 개발하고 마케팅함으로써 이러한 추세를 활용할 수 있습니다.
예를 들어,
- 2022년 6월, 미국 국립의학도서관(National Library of Medicine)에 발표된 논문에 따르면, 척수 손상(SCI)의 발생률과 부담은 지난 30년 동안 증가했습니다. 남성과 노인이 여성과 젊은층보다 더 큰 영향을 받았으며, 낙상과 교통사고가 대부분의 척수 손상의 주요 원인이었습니다.
- 세계보건기구(WHO)가 발표한 자료에 따르면, 2024년 4월 기준 전 세계적으로 1,500만 명이 넘는 사람들이 척수 손상(SCI)을 겪고 있습니다. 대부분의 SCI는 낙상, 교통사고, 폭력 등 외상으로 인해 발생합니다.
외상성 손상 발생률 증가는 전 세계 척수 손상 치료 시장의 상당한 확장을 촉진하며, 다양한 의료 분야에 걸쳐 기회를 창출하고 있습니다. 이러한 환자 집단의 특정 요구에 맞춘 혁신적이고 효과적인 솔루션에 집중하는 것이 매우 중요합니다. 척수 손상 환자의 증가하는 수요를 충족하고 치료 결과를 개선하기 위해서는 첨단 치료법의 지속적인 개발 및 제공이 매우 중요합니다.
- 인공지능과 빅데이터 분석의 통합
AI 기반 알고리즘과 방대한 환자 데이터를 활용하여 연구자들은 이전에는 알려지지 않았던 패턴과 상관관계를 파악하여 더욱 효과적인 치료 전략과 개인 맞춤형 치료 계획을 개발할 수 있습니다. AI는 치료 결과 예측, 재활 계획 최적화, 환자 치료 프로세스 간소화에 도움을 줄 수 있습니다. 또한, 머신러닝 알고리즘을 사용하면 고위험 환자를 파악하고, 적극적인 개입을 가능하게 하며, 합병증 발생 가능성을 줄이는 데 도움이 될 수 있습니다. 이러한 데이터 기반 접근 방식은 더욱 정확한 진단 도구와 예측 모델 개발을 촉진하여 궁극적으로 척수 손상 환자의 치료 질을 향상시킬 수 있습니다.
예를 들어,
- 2023년 4월, 미국 국립의학도서관(National Library of Medicine)에 발표된 논문에 따르면, 급성 척수 손상 치료에서 생성 AI는 활력 징후, 검사 결과 및 기타 환자 데이터를 분석하여 욕창, 요로 감염 또는 기타 합병증 발생 가능성을 예측할 수 있습니다. 이는 임상의가 조기에 개입하여 환자 치료 결과를 개선하고 의료비를 절감하는 데 도움이 될 수 있습니다.
- 2023년 4월, 유럽 방사선학 저널(European Journal of Radiology)에 게재된 논문에 따르면, 척추 분야의 초기 AI 적용은 국소 병변 평가에 있어 놀라운 유용성을 보였습니다. 예를 들어, 일부 알고리즘은 정상적으로 보이는 MRI 영상에서는 잘 드러나지 않는 척수의 초기 압박성 척수병증 변화와 탈수초화 병변을 감지할 수 있었습니다.
제조업체는 AI 기반 인사이트를 활용하여 각 환자의 고유한 요구에 맞는 더욱 효과적이고 적응력 있는 보조 기술을 설계하고 개발할 수 있습니다. 또한 원격 진료 및 원격 모니터링 플랫폼을 활용하면 환자 참여와 순응도를 높일 수 있으며, AI 기반 챗봇과 가상 비서는 환자에게 24시간 지원과 안내를 제공할 수 있습니다. 척수 손상 치료 시장의 이해관계자들은 AI와 빅데이터 분석을 도입함으로써 환자 치료에 혁신을 일으키고, 의료 서비스의 효율성을 높이며, 산업 성장을 촉진할 수 있습니다. 이러한 기술과 의료의 융합은 더욱 효과적인 치료 방식, 환자 치료 결과 개선, 그리고 더욱 개인화된 척수 손상 치료 접근 방식을 창출할 수 있습니다.
제약/도전
- 척수 치료의 잠재적 위험, 부작용 및 합병증
현재 척수 손상에 대한 일부 치료법(수술적 개입 및 약물 치료 포함)은 다양한 부작용, 합병증 및 장기적인 위험을 수반합니다. 수술은 특정 손상에 필수적이지만, 감염, 출혈 또는 주변 조직 손상을 초래할 수 있으며, 이는 환자의 상태를 더욱 악화시킬 수 있습니다. 또한 수술로 인해 마비나 운동 기능 상실과 같은 신경학적 합병증이 발생할 가능성도 항상 존재합니다. 약물 치료의 경우, 메스꺼움, 현기증, 진통제 의존과 같은 부작용이 회복 과정을 복잡하게 만들 수 있습니다. 더 심각한 경우, 통증이나 염증을 관리하는 데 사용되는 약물은 장기 손상이나 면역 억제와 같은 장기적인 문제를 초래할 수 있습니다. 이러한 위험 때문에 많은 환자가 이러한 치료 옵션을 선택하지 않을 수 있으며, 특히 건강 악화나 새로운 합병증 발생을 우려하는 경우 더욱 그렇습니다. 결과적으로 일부 환자는 광범위한 임상 시험을 거치지 않은 대체 요법이나 비전통적 접근법을 선택하여 이러한 치료를 피하거나 지연할 수 있습니다. 전통적인 치료법을 거부하는 이러한 태도는 궁극적으로 환자의 회복 과정에 악영향을 미쳐, 호전이 지연되거나 전반적인 치료 효과가 감소할 수 있습니다. 더욱이, 척수 손상으로 인한 평생 후유증에 직면한 환자의 경우, 지속적인 치료 위험과 합병증으로 인한 부담은 신체적, 정서적 고통을 가중시켜 치료 결정을 더욱 어렵게 만들 수 있습니다.
예를 들어
- 2024년 12월, NCBI에 발표된 논문에 따르면 만성 또는 종양성 척수 손상은 지속적인 요통, 체질적 징후(체중 감소, 발열, 식욕 부진), 그리고 점진적인 감각운동성 약화와 같은 증상을 보일 수 있습니다. 병변이 커짐에 따라 파악 및 이동 능력 상실을 포함한 운동 기능 저하가 나타날 수 있습니다. 위험 요인으로는 흡연, 이전 암 치료, 결핵 노출, 최근 수술, 그리고 면역 억제 등이 있습니다.
- 2025년 1월, NCBI에 발표된 논문에 따르면 척수 손상(SCI)은 폐렴, 혈액 순환 장애, 근육 경직, 자율신경 반사 부전, 욕창, 신경인성 통증, 방광 및 장 문제, 성기능 장애, 우울증 등 다양한 합병증을 유발할 수 있습니다. 환자는 이러한 문제를 관리하기 위해 신중한 모니터링, 예방 조치, 그리고 약물 치료, 물리 치료, 정서적 지원과 같은 전문적인 치료가 필요합니다.
척수 손상 회복에 수술적 및 약물적 치료가 필수적이지만, 감염, 신경학적 합병증, 장기적인 부작용 등 심각한 위험을 동반합니다. 이러한 잠재적 단점 때문에 환자들은 추가적인 손상이나 삶의 질 저하를 두려워하여 치료를 시작하거나 완전히 받아들이지 못하는 경우가 많습니다. 결과적으로 환자들은 항상 효과가 있는 것은 아닐 수 있는 대체 요법에 의존하게 됩니다. 이는 더 안전하고 효과적인 치료 옵션의 필요성을 강조하며, 척수 손상 환자를 더 잘 지원하기 위해 잠재적 위험과 회복 가능성을 균형 있게 고려한 종합적인 치료 제공의 중요성을 강조합니다.
- 척수 손상 치료와 관련된 제한된 이해
척수 손상(SCI)의 복잡한 병태생리에 대한 이해가 부족하여 효과적인 치료법 개발을 크게 저해하고 있으며, 전 세계 SCI 치료 시장에 상당한 난관을 초래하고 있습니다. SCI는 분자 및 세포 수준에서 일련의 사건들을 수반하며, 신경 손상, 염증, 그리고 신경교반흔 형성을 초래하고, 이러한 모든 과정은 기능적 결함을 초래합니다. 이러한 복잡한 과정에 대한 완전한 이해가 부족하면 정확한 치료 목표를 설정하고 신경 재생과 기능 회복을 효과적으로 촉진할 수 있는 중재를 설계하는 데 어려움을 겪습니다. 결과적으로, 현재 많은 치료법들은 SCI의 근본 원인을 해결하기보다는 증상 관리와 합병증 예방에 집중하고 있습니다.
예를 들어,
- 2020년 10월 미국 국립의학도서관에 게재된 논문에 따르면, 복잡한 특성, 풍부한 불일치, SCI 후 복잡한 병태생리학적 결과 등 이질적인 요인들이 SCI 치료에 대한 이해가 부족하고 치료가 실패하는 주요 원인으로 지적됐다.
- 2023년 2월 옥스포드 대학 출판부에 발표된 논문에 따르면 SCI의 병태생리는 복잡하고 다면적이어서 특정 측면이나 과정에 작용하는 개별 치료는 SCI 후 신경 재생과 기능 회복을 유도하기에 부적절합니다.
이러한 지식 격차는 개인 맞춤형 치료 전략 개발을 저해합니다. 척수 손상은 획일적인 질환이 아니며, 환자마다 손상 심각도, 신경학적 손상, 그리고 기능적 한계가 다릅니다. 각 환자의 손상을 유발하는 구체적인 기전을 철저히 이해하지 못하면 환자의 필요에 맞춰 치료 계획을 수립하는 것이 어려워집니다. 이는 최적의 치료 결과를 얻지 못하고 환자 만족도가 저하되는 결과를 초래할 수 있습니다. 더욱이, 척수 손상에 대한 이해 부족은 정확한 진단 도구와 바이오마커 개발을 저해하여 치료 효능을 모니터링하고 장기적인 결과를 예측하는 것을 어렵게 만듭니다. 이러한 과제를 극복하기 위해서는 척수 손상의 복잡성을 이해하고 더욱 효과적이고 표적화된 치료법을 개발하기 위한 기초 연구 및 중개 연구에 상당한 투자가 필요합니다.
아시아 태평양 척수 손상 치료 시장 범위
시장은 유형, 부상 유형, 부상 수준, 성별, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다. 이러한 세그먼트의 성장은 산업 내 저조한 성장 세그먼트를 분석하고 사용자에게 핵심 시장 응용 분야를 파악하기 위한 전략적 의사 결정에 도움이 되는 귀중한 시장 개요와 시장 통찰력을 제공하는 데 도움이 될 것입니다.
유형
- 비운영 관리
- 요법
- 재활 치료
- 물리적
- 작업 치료 또는 언어 치료
- 척추강 내 바클로펜 치료(IBT)
- 재활 치료
- 약물
- 항경련제
- 코르티코스테로이드
- 메틸프레드니솔론
- 덱사메타손
- 항우울제
- SSRIS(선택적 세로토닌 재흡수 억제제)
- Snris(세로토닌 및 노르에피네프린 재흡수 억제제)
- 삼환계 약물
- 불안 치료제
- 진경제 및 근육 이완제
- 벤조디아제핀
- 알파-2 작용제
- 기타 가바 작용제
- 기타
- NSAIDs
- 이부프로펜
- 나프록센
- 기타
- 마약성 진통제
- 항생제
- β-락탐(페니실린, 세팔로스포린)
- 마크로라이드(아지트로마이신, 에리스로마이신)
- 미노사이클린(테트라사이클린 계열)
- 다프손
- 기타(플루오로퀴놀론, 아미노글리코사이드 등)
- 요법
- 약물 유형별
- 일반적인
- 브랜드
- 메드롤
- 리오레살
- 리리카
- 뉴론틴
- 자나플렉스
- 그랄리세
- 호리즌트
- 릴루텍
- 관리 경로별
- 경구
- 정제
- 캡슐
- 비경구
- 경피 패치
- 운영 관리
- 감압 수술
- 디스크 절제술 또는 미세 디스크 절제술
- 척추절제술
- 후방 미세 디스크 절제술/ 미세 감압술
- 구멍 절제술
- 재건 척추 수술
- 후방 경추 추궁절제술
- 추궁절개술
- 디스크 교체
- 인공 경추 디스크 이식
- 인공 디스크 수술/척추 인공관절 수술
- 디스크 및 소관절 제거
- 전방 경추 디스크 절제술
- 척추 융합술
- 요추 척추 유합술
- 경추 척추 융합술
- 육분의 퓨전
- 내측면 절제술
- 두 개의 면 관절 제거
- 한쪽 면 관절 제거
- 기타
- 감압 수술
부상 유형
- 척수 손상
- 부분 척수 손상
부상 수준
- 경추 척수 손상
- 척수 손상
- 부분 척수 손상
- 흉부 척수 손상
- 척수 손상
- 부분 척수 손상
- 요추 척수 손상
- 척수 손상
- 부분 척수 손상
- 천골 척수 손상
- 척수 손상
- 부분 척수 손상
성별
- 남성
- 성인
- 노인성
- 어린이들
- 여성
- 성인
- 노인성
- 어린이들
최종 사용자
- 병원
- 트라우마 센터
- 전문 클리닉
- 클리닉
- 외래 및 연구 센터
- 기타
유통 채널
- 병원 약국
- 소매 약국
- 온라인 약국
아시아 태평양 척수 손상 치료 시장 지역 분석
위에 언급된 대로 국가, 유형, 부상 유형, 부상 수준, 성별, 최종 사용자 및 유통 채널별로 시장을 분석하고 시장 규모에 대한 통찰력과 추세를 제공합니다.
척수 손상 치료 시장이 포함된 국가는 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀 및 기타 아시아 태평양 지역입니다.
중국은 선진 의료 인프라와 막대한 연구개발 투자를 바탕으로 의료 시장을 선도할 것으로 예상됩니다. 우호적인 규제 정책과 탄탄한 산학 협력 또한 혁신과 시장 성장을 촉진하는 데 중요한 역할을 합니다.
일본은 의료 인프라에 대한 막대한 투자와 신기술 도입에 힘입어 세계 척수 손상 치료 시장에서 가장 빠르게 성장하는 지역입니다. 또한, 정부 지원 확대와 도시화 및 산업 성장으로 인한 척추 손상 발생률 증가는 시장 수요를 더욱 촉진하고 있습니다.
보고서의 국가별 섹션은 개별 시장 영향 요인과 국내 시장 규제 변화도 제시하며, 이는 현재 및 미래 시장 동향에 영향을 미칩니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 동향, 포터의 5대 경쟁 요인 분석, 사례 연구 등의 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 활용됩니다. 또한, 아시아 태평양 지역 브랜드의 존재 및 가용성, 그리고 국내 및 국내 브랜드와의 경쟁 심화 또는 부족으로 인해 직면하는 과제, 국내 관세 및 무역 경로의 영향 등을 고려하여 국가별 데이터 예측 분석을 제공합니다.
아시아 태평양 척수 손상 치료 시장 점유율
시장 경쟁 구도는 경쟁사별 세부 정보를 제공합니다. 여기에는 회사 개요, 회사 재무 상태, 매출 창출, 시장 잠재력, 연구 개발 투자, 신규 시장 진출 계획, 아시아 태평양 지역 진출 현황, 생산 시설 및 설비, 생산 능력, 회사의 강점과 약점, 제품 출시, 제품 종류 및 범위, 응용 분야별 시장 지배력 등이 포함됩니다. 위에 제시된 데이터는 해당 회사의 시장 집중도와 관련된 내용만 포함합니다.
아시아 태평양 척수 손상 치료 시장 에서 활동하는 선두 기업은 다음과 같습니다.
- 노바티스 AG(스위스)
- 화이자(미국)
- 메드트로닉(아일랜드)
- 짐머 바이오멧(미국)
- 애벗(미국)
- Amneal Pharmaceuticals LLC(미국)
- 사노피(프랑스)
- Axonis Therapeutics(미국)
- Zydus 그룹(인도)
- Lineage Cell Therapeutics, Inc. (미국)
- Sun Pharmaceutical Industries Ltd.(인도)
- 캠버 파마슈티컬스(Camber Pharmaceuticals, Inc.) (미국)
- Dr. Reddy's Laboratories Ltd. (인도)
- Teva Pharmaceuticals US, Inc. (이스라엘)
- Niksan Pharmaceuticals(인도)
- Covis Pharma GmbH(스위스)
- 인도 척추 손상 센터(인도)
- 주빌런트 카디스타 파마슈티컬스(미국)
- 존슨앤존슨(미국)
- Nervgen Pharma Corp(캐나다)
- 애드바케어 파마(미국)
- 보스턴 사이언티픽(미국)
- 바수다 파마(인도)
- 에노마크(인도)
- Glenmark Pharmaceuticals US Inc.(미국)
- 이노바 파마슈티컬스(호주)
- 글로버스 메디컬(미국)
- 짐비 주식회사(미국)
- Bioaxone(캐나다)
아시아 태평양 척수 손상 치료 시장의 최신 동향
- 2023년 5월, 애보트는 FDA가 비수술적 허리 통증으로 알려진, 허리 수술을 받지 않았거나 받을 자격이 없는 사람들의 만성 허리 통증 치료를 위해 척수 자극(SCS) 기기를 승인했다고 발표했습니다.
- 2025년 1월, 애보트는 자사의 독점 기술인 BurstDR 척수 자극(SCS) 기술이 만성 통증, 특히 허리와 다리 통증 환자에게 장기적이고 지속적인 통증 완화 효과를 제공하는 것을 보여주는 새로운 4년 데이터를 발표했습니다. 이 데이터는 환자들이 치료에 대해 높은 만족도를 보인다는 것을 다시 한번 입증하며, 다년간의 추적 연구의 4년차 결과를 나타내며, 플로리다주 올랜도에서 개최되는 북미 신경조절학회(NANS) 2025 연례 회의에서 발표될 예정입니다.
- 2024년 8월, 짐머 바이오멧(Zimmer Biomet)은 오쏘그리드 시스템즈(OrthoGrid Systems) 인수 계약을 체결하고 오쏘그리드의 AI 기반 고관절 AI 수술 유도 플랫폼을 통해 고관절 포트폴리오를 확장했습니다. 이번 인수에는 AI 기반 투시 검사 기반 시스템이 포함되어 수술의 정확도와 효율성을 향상시킵니다.
- 2020년 12월, 캠버 파마슈티컬스(Camber Pharmaceuticals)는 리오레살(Lioresal)의 제네릭 버전인 바클로펜 정(Baclofen Tablets)을 출시했습니다. 바클로펜은 다발성 경화증 및 척수 손상과 같은 질환의 근육통, 근육 경련, 경직 치료에 사용됩니다. 10mg 및 20mg 용량으로 출시되며, 근육을 이완시키고 이러한 질환 환자의 불편함을 완화하여 통증을 완화합니다.
- Globus Medical은 2020년 12월 미국 최대의 그룹 구매 기관인 Premier와 그룹 구매 계약을 체결했다고 발표했습니다. 이 계약을 통해 회사는 시장에서 신뢰도를 높이고 향후 매출 증대로 이어질 것으로 기대됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: REGULATIONS
5.1 ONGOING COMPLIANCE AND UPDATES:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING COLLABORATION AND EXPANDING PARTNERSHIPS
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN TREATMENT METHODS
6.1.3 INCREASING HEALTHCARE EXPENDITURE
6.1.4 ENHANCED REHABILITATION TECHNIQUES
6.2 RESTRAINTS
6.2.1 POTENTIAL RISKS, SIDE EFFECTS, AND COMPLICATIONS OF SPINAL CORD TREATMENTS
6.2.2 REGULATORY BARRIERS LIMIT MARKET GROWTH BY DELAYING TREATMENT APPROVALS AND ACCESSIBILITY
6.3 OPPORTUNITIES
6.3.1 RISING GERIATRIC POPULATION
6.3.2 RISING INCIDENCE OF TRAUMATIC INJURIES
6.3.3 INCORPORATION OF ARTIFICIAL INTELLIGENCE AND BIG DATA ANALYTICS
6.4 CHALLENGES
6.4.1 LIMITED UNDERSTANDING RELATED TO SPINAL CORD INJURY TREATMENTS
6.4.2 HIGH COSTS ASSOCIATED WITH THE TREATMENTS
7 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY TYPE
7.1 OVERVIEW
7.2 NON-OPERATIVE MANAGEMENT
7.2.1 THERAPY
7.2.1.1 Rehabilitation Therapy
7.2.1.1.1 PHYSICAL
7.2.1.1.2 OCCUPATIONAL OR SPEECH THERAPY
7.2.1.2 INTRATHECAL BACLOFEN THERAPY (IBT)
7.2.2 MEDICATION
7.2.2.1 ANTICONVULSANTS
7.2.2.1.1 Pregabalin
7.2.2.1.2 Gabapentin
7.2.2.1.3 Others
7.2.2.2 CORTICOSTEROIDS
7.2.2.2.1 Methylprednisolone
7.2.2.2.2 Dexamethasone
7.2.2.3 ANTIDEPRESSANTS
7.2.2.3.1 SSRIs (Selective Serotonin Reuptake Inhibitors)
7.2.2.3.2 SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors)
7.2.2.3.3 Tricyclic Drugs
7.2.2.3.4 Anxiety Medications
7.2.2.4 ANTISPASMODICS AND MUSCLE RELAXANTS
7.2.2.4.1 Benzodiazepines
7.2.2.4.2 Alpha-2 Agonists
7.2.2.4.3 Other GABA Agonists
7.2.2.4.4 Others
7.2.2.5 NSAIDS
7.2.2.5.1 Ibuprofen
7.2.2.5.2 Naproxen
7.2.2.5.3 Others
7.2.2.6 NARCOTIC ANALGESICS
7.2.2.7 ANTIBIOTICS
7.2.2.7.1 β-Lactams (Penicillins, Cephalosporins)
7.2.2.7.2 Macrolides (Azithromycin, Erythromycin)
7.2.2.7.3 Minocycline (Tetracycline Type)
7.2.2.7.4 Dapsone
7.2.2.7.5 Others (Fluoroquinolones, Aminoglycosides, etc.)
7.2.2.8 Medrol
7.2.2.9 Lioresal
7.2.2.10 Lyrica
7.2.2.11 Neurontin
7.2.2.12 Zanaflex
7.2.2.13 Gralise
7.2.2.14 Rilutek
7.3 OPERATIVE MANAGEMENT
7.3.1 DECOMPRESSION SURGERY
7.3.1.1 Discectomy Or Microdiscectomy
7.3.1.2 Laminectomy
7.3.1.3 Posterior Microdiscectomy/ Microdecompression
7.3.1.4 Foraminectomy
7.3.1.5 Reconstructive Spinal Surgery
7.3.1.6 Posterior Cervical Laminectomy
7.3.1.7 Laminotomy
7.3.2 DISC REPLACEMENT
7.3.2.1 Artificial Cervical Disc Implantation
7.3.2.2 Artificial Disc Surgery/ Spinal Arthroplasty
7.3.3 DISC AND FACET JOINT REMOVAL
7.3.3.1 Anterior Cervical Discectomy
7.3.3.2 Spinal Fusion
7.3.3.2.1 Lumbar Spinal Fusion
7.3.3.2.2 Cervical Spinal Fusion
7.3.3.2.3 Sextant Fusion
7.3.3.3 Medial Facetectomy
7.3.3.3.1 REMOVE TWO FACET JOINT
7.3.3.3.2 REMOVE ONE FACET JOINT
8 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY
8.1 OVERVIEW
8.2 CERVICAL SPINAL CORD INJURIES
8.2.1 COMPLETE SPINAL CORD INJURIES
8.2.2 PARTIAL SPINAL CORD INJURIES
8.3 THORACIC SPINAL CORD INJURIES
8.3.1 COMPLETE SPINAL CORD INJURIES
8.3.2 PARTIAL SPINAL CORD INJURIES
8.4 LUMBAR SPINAL CORD INJURIES
8.4.1 COMPLETE SPINAL CORD INJURIES
8.4.2 PARTIAL SPINAL CORD INJURIES
8.5 SACRAL SPINAL CORD INJURIES
8.5.1 COMPLETE SPINAL CORD INJURIES
8.5.2 PARTIAL SPINAL CORD INJURIES
9 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE
9.1 OVERVIEW
9.2 COMPLETE SPINAL CORD INJURIES
9.3 PARTIAL SPINAL CORD INJURIES
10 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY GENDER
10.1 OVERVIEW
10.2 MALE
10.2.1 ADULT
10.2.2 GERIATIC
10.2.3 CHILDREN
10.3 FEMALE
10.3.1 ADULT
10.3.2 GERIATIC
10.3.3 CHILDREN
11 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 TRAUMA CENTERS
11.4 SPECIALTY CLINICS
11.5 CLINICS
11.6 AMBULATORY AND RESEARCH CENTERS
11.7 OTHERS
12 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY REGION
12.1 ASIA-PACIFIC
12.1.1 CHINA
12.1.2 JAPAN
12.1.3 INDIA
12.1.4 SOUTH KOREA
12.1.5 AUSTRALIA
12.1.6 SINGAPORE
12.1.7 THAILAND
12.1.8 MALAYSIA
12.1.9 INDONESIA
12.1.10 TAIWAN
12.1.11 NEW ZEALAND
12.1.12 PHILIPPINES
12.1.13 VIETNAM
12.1.14 REST OF ASIA-PACIFIC
13 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 PFIZER INC.
15.1.1 COMPANY SHARE ANALYSIS
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 ABBOTT
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 MEDTRONIC
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 NOVARTIS AG
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 ZIMMER BIOMET
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 AMNEAL PHARMACEUTICALS LLC
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 AXONIS THERAPEUTICS
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 ADVACARE PHARMA
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BIOAXONE BIOSCIENCES
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BOSTON SCIENTIFIC CORPORATION
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 COVIS PHARMA GMBH.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 CAMBER PHARMACEUTICALS, INC
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 DR. REDDY’S LABORATORIES LTD
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENT
15.14 ENOMARK PHARMA
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 GLENMARK PHARMACEUTICALS INC.,
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENT
15.16 GLOBUS MEDICAL
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS/NEWS
15.17 INOVA PHARMACEUTICALS
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 INDIAN SPINAL INJURIES CENTRE
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 JUBILANT CADISTA PHARMACEUTICALS INC.
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.2 JOHNSON & JOHNSON SERVICES, INC
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
15.21 LINEAGE CELL THERAPEUTICS, INC.
15.21.1 COMPANY SNAPSHOT
15.21.2 ANNUAL REVENUE
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENT
15.22 NERVGEN PHARMA CORP.
15.22.1 COMPANY SNAPSHOT
15.22.2 REVENUE ANALYSIS
15.22.3 PRODUCT PIPELINE PORTFOLIO
15.22.4 RECENT DEVELOPMENT
15.23 NIKSAN PHARMACEUTICAL
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENT
15.24 SUN PHARMACEUTICAL INDUSTRIES LTD.
15.24.1 COMPANY SNAPSHOT
15.24.2 REVENUE ANALYSIS
15.24.3 PRODUCT PORTFOLIO
15.24.4 RECENT DEVELOPMENT
15.25 SANOFI
15.25.1 COMPANY SNAPSHOT
15.25.2 REVENUE ANALYSIS
15.25.3 PRODUCT PORTFOLIO
15.25.4 RECENT DEVELOPMENT
15.26 TEVA PHARMACEUTICALS USA, INC.
15.26.1 COMPANY SNAPSHOT
15.26.2 REVENUE ANALYSIS
15.26.3 PRODUCT PORTFOLIO
15.26.4 RECENT DEVELOPMENT
15.27 VASUDHA PHARMA
15.27.1 COMPANY SNAPSHOT
15.27.2 PRODUCT PORTFOLIO
15.27.3 RECENT DEVELOPMENT
15.28 ZIMVIE INC.
15.28.1 COMPANY SNAPSHOT
15.28.2 REVENUE ANALYSIS
15.28.3 PRODUCT PORTFOLIO
15.28.4 RECENT NEWS
15.29 ZYDUS GROUP
15.29.1 COMPANY SNAPSHOT
15.29.2 REVENUE ANALYSIS
15.29.3 PRODUCT PORTFOLIO
15.29.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
표 목록
TABLE 1 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 ASIA-PACIFIC NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 9 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 10 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 12 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 13 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 15 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 16 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE 2018-2032 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 18 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 19 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 21 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 22 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 24 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 25 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 29 ASIA-PACIFIC OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC SPINAL FUSION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE 2018-2032 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC COMPLETE SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC PARTIAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC SPINAL CORD INJURY TREA TMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 51 ASIA-PACIFIC FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 52 ASIA-PACIFIC FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 53 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 54 ASIA-PACIFIC HOSPITALS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 55 ASIA-PACIFIC TRAUMA CENTERS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 56 ASIA-PACIFIC SPECIALITY CLINICS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 57 ASIA-PACIFIC CLINICS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 58 ASIA-PACIFIC AMBULATORY AND RESEARCH CENTERS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 59 ASIA-PACIFIC OTHERS IN SPINAL CORD INJURY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 60 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 61 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 ASIA-PACIFIC NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 63 ASIA-PACIFIC THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 ASIA-PACIFIC REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 65 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 68 ASIA-PACIFIC ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 69 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 70 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 71 ASIA-PACIFIC CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 72 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 73 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 74 ASIA-PACIFIC ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 75 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 76 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 77 ASIA-PACIFIC ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 78 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 79 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 80 ASIA-PACIFIC NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 81 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 82 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 83 ASIA-PACIFIC ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 84 ASIA-PACIFIC OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 ASIA-PACIFIC DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 86 ASIA-PACIFIC DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 87 ASIA-PACIFIC DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 ASIA-PACIFIC SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 ASIA-PACIFIC MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 90 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 91 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 92 ASIA-PACIFIC CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 93 ASIA-PACIFIC THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 94 ASIA-PACIFIC LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 ASIA-PACIFIC SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 ASIA-PACIFIC BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 98 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 99 ASIA-PACIFIC ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 100 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 101 ASIA-PACIFIC MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 102 ASIA-PACIFIC FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 103 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 104 ASIA-PACIFIC MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 105 CHINA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 CHINA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 CHINA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 CHINA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 109 CHINA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 110 CHINA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 CHINA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 112 CHINA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 113 CHINA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 114 CHINA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 115 CHINA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 116 CHINA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 CHINA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 118 CHINA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 119 CHINA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 120 CHINA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 121 CHINA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 122 CHINA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 123 CHINA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 124 CHINA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 125 CHINA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 126 CHINA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 127 CHINA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 128 CHINA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 129 CHINA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 130 CHINA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 131 CHINA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 CHINA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 133 CHINA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 CHINA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 135 CHINA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 136 CHINA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 137 CHINA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 CHINA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 139 CHINA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 140 CHINA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 141 CHINA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 142 CHINA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 143 CHINA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 144 CHINA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 145 CHINA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 146 CHINA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 147 CHINA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 148 CHINA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 149 JAPAN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 150 JAPAN NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 151 JAPAN THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 152 JAPAN REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 JAPAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 JAPAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 155 JAPAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 156 JAPAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 157 JAPAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 158 JAPAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 159 JAPAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 160 JAPAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 161 JAPAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 162 JAPAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 163 JAPAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 164 JAPAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 165 JAPAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 166 JAPAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 JAPAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 168 JAPAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 169 JAPAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 170 JAPAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 171 JAPAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 172 JAPAN OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 173 JAPAN DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 174 JAPAN DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 175 JAPAN DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 176 JAPAN SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 177 JAPAN MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 178 JAPAN SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 JAPAN SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 180 JAPAN CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 181 JAPAN THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 182 JAPAN LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 183 JAPAN SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 JAPAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 185 JAPAN BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 186 JAPAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 187 JAPAN ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 JAPAN SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 189 JAPAN MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 190 JAPAN FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 191 JAPAN SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 192 JAPAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 193 INDIA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 194 INDIA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 195 INDIA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 INDIA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 197 INDIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 198 INDIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 199 INDIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 200 INDIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 201 INDIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 202 INDIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 203 INDIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 204 INDIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 INDIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 206 INDIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 207 INDIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 208 INDIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 209 INDIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 210 INDIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 211 INDIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 212 INDIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 213 INDIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 214 INDIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 215 INDIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 216 INDIA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 217 INDIA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 218 INDIA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 INDIA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 220 INDIA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 221 INDIA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 222 INDIA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 INDIA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 224 INDIA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 INDIA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 226 INDIA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 INDIA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 228 INDIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 229 INDIA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 230 INDIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 231 INDIA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 232 INDIA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 233 INDIA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 234 INDIA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 235 INDIA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 236 INDIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 237 SOUTH KOREA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 238 SOUTH KOREA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 239 SOUTH KOREA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 SOUTH KOREA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 241 SOUTH KOREA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 242 SOUTH KOREA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 243 SOUTH KOREA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 244 SOUTH KOREA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 245 SOUTH KOREA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 246 SOUTH KOREA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 247 SOUTH KOREA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 248 SOUTH KOREA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 249 SOUTH KOREA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 250 SOUTH KOREA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 251 SOUTH KOREA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 SOUTH KOREA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 253 SOUTH KOREA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 254 SOUTH KOREA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 255 SOUTH KOREA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 256 SOUTH KOREA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 257 SOUTH KOREA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 258 SOUTH KOREA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 259 SOUTH KOREA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 260 SOUTH KOREA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 261 SOUTH KOREA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 262 SOUTH KOREA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 263 SOUTH KOREA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 264 SOUTH KOREA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 265 SOUTH KOREA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 266 SOUTH KOREA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 267 SOUTH KOREA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 268 SOUTH KOREA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 269 SOUTH KOREA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 270 SOUTH KOREA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 271 SOUTH KOREA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 272 SOUTH KOREA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 273 SOUTH KOREA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 274 SOUTH KOREA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 275 SOUTH KOREA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 276 SOUTH KOREA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 277 SOUTH KOREA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 278 SOUTH KOREA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 279 SOUTH KOREA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 280 SOUTH KOREA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 281 AUSTRALIA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 282 AUSTRALIA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 283 AUSTRALIA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 284 AUSTRALIA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 285 AUSTRALIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 286 AUSTRALIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 287 AUSTRALIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 288 AUSTRALIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 289 AUSTRALIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 290 AUSTRALIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 291 AUSTRALIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 292 AUSTRALIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 293 AUSTRALIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 294 AUSTRALIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 295 AUSTRALIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 296 AUSTRALIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 297 AUSTRALIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 298 AUSTRALIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 299 AUSTRALIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 300 AUSTRALIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 301 AUSTRALIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 302 AUSTRALIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 303 AUSTRALIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 304 AUSTRALIA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 305 AUSTRALIA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 306 AUSTRALIA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 307 AUSTRALIA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 AUSTRALIA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 309 AUSTRALIA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 AUSTRALIA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 311 AUSTRALIA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 312 AUSTRALIA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 313 AUSTRALIA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 AUSTRALIA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 315 AUSTRALIA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 316 AUSTRALIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 317 AUSTRALIA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 318 AUSTRALIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 319 AUSTRALIA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 320 AUSTRALIA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 321 AUSTRALIA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 322 AUSTRALIA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 323 AUSTRALIA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 324 AUSTRALIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 325 SINGAPORE SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 326 SINGAPORE NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 SINGAPORE THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 328 SINGAPORE REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 329 SINGAPORE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 330 SINGAPORE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 331 SINGAPORE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 332 SINGAPORE ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 333 SINGAPORE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 334 SINGAPORE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 335 SINGAPORE CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 336 SINGAPORE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 SINGAPORE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 338 SINGAPORE ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 339 SINGAPORE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 340 SINGAPORE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 341 SINGAPORE ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 342 SINGAPORE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 343 SINGAPORE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 344 SINGAPORE NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 345 SINGAPORE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 346 SINGAPORE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 347 SINGAPORE ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 348 SINGAPORE OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 349 SINGAPORE DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 350 SINGAPORE DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 351 SINGAPORE DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 352 SINGAPORE SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 353 SINGAPORE MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 354 SINGAPORE SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 355 SINGAPORE SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 356 SINGAPORE CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 357 SINGAPORE THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 358 SINGAPORE LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 359 SINGAPORE SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 SINGAPORE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 361 SINGAPORE BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 362 SINGAPORE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 363 SINGAPORE ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 364 SINGAPORE SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 365 SINGAPORE MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 366 SINGAPORE FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 367 SINGAPORE SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 368 SINGAPORE MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 369 THAILAND SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 THAILAND NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 371 THAILAND THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 372 THAILAND REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 373 THAILAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 374 THAILAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 375 THAILAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 376 THAILAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 377 THAILAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 378 THAILAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 379 THAILAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 380 THAILAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 381 THAILAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 382 THAILAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 383 THAILAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 384 THAILAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 385 THAILAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 386 THAILAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 387 THAILAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 388 THAILAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 389 THAILAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 390 THAILAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 391 THAILAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 392 THAILAND OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 THAILAND DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 394 THAILAND DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 THAILAND DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 396 THAILAND SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 397 THAILAND MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 398 THAILAND SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 THAILAND SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 400 THAILAND CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 401 THAILAND THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 402 THAILAND LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 403 THAILAND SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 404 THAILAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 405 THAILAND BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 406 THAILAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 407 THAILAND ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 THAILAND SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 409 THAILAND MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 410 THAILAND FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 411 THAILAND SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 412 THAILAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 413 MALAYSIA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 414 MALAYSIA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 415 MALAYSIA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 416 MALAYSIA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 417 MALAYSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 418 MALAYSIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 419 MALAYSIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 420 MALAYSIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 421 MALAYSIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 422 MALAYSIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 423 MALAYSIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 424 MALAYSIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 425 MALAYSIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 426 MALAYSIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 427 MALAYSIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 428 MALAYSIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 429 MALAYSIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 430 MALAYSIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 431 MALAYSIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 432 MALAYSIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 433 MALAYSIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 434 MALAYSIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 435 MALAYSIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 436 MALAYSIA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 437 MALAYSIA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 438 MALAYSIA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 439 MALAYSIA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 440 MALAYSIA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 441 MALAYSIA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 442 MALAYSIA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 443 MALAYSIA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 444 MALAYSIA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 445 MALAYSIA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 446 MALAYSIA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 447 MALAYSIA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 448 MALAYSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 449 MALAYSIA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 450 MALAYSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 451 MALAYSIA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 452 MALAYSIA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 453 MALAYSIA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 454 MALAYSIA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 455 MALAYSIA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 456 MALAYSIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 457 INDONESIA SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 458 INDONESIA NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 459 INDONESIA THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 460 INDONESIA REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 461 INDONESIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 462 INDONESIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 463 INDONESIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 464 INDONESIA ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 465 INDONESIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 466 INDONESIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 467 INDONESIA CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 468 INDONESIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 469 INDONESIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 470 INDONESIA ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 471 INDONESIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 472 INDONESIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 473 INDONESIA ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 474 INDONESIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 475 INDONESIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 476 INDONESIA NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 477 INDONESIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 478 INDONESIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 479 INDONESIA ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 480 INDONESIA OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 481 INDONESIA DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 482 INDONESIA DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 483 INDONESIA DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 484 INDONESIA SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 485 INDONESIA MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 486 INDONESIA SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 487 INDONESIA SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 488 INDONESIA CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 489 INDONESIA THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 490 INDONESIA LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 491 INDONESIA SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 492 INDONESIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 493 INDONESIA BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 494 INDONESIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 495 INDONESIA ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 496 INDONESIA SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 497 INDONESIA MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 498 INDONESIA FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 499 INDONESIA SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 500 INDONESIA MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 501 TAIWAN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 502 TAIWAN NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 503 TAIWAN THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 504 TAIWAN REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 505 TAIWAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 506 TAIWAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 507 TAIWAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 508 TAIWAN ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 509 TAIWAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 510 TAIWAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 511 TAIWAN CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 512 TAIWAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 513 TAIWAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 514 TAIWAN ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 515 TAIWAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 516 TAIWAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 517 TAIWAN ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 518 TAIWAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 519 TAIWAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 520 TAIWAN NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 521 TAIWAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 522 TAIWAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 523 TAIWAN ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 524 TAIWAN OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 525 TAIWAN DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 526 TAIWAN DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 527 TAIWAN DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 528 TAIWAN SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 529 TAIWAN MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 530 TAIWAN SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 531 TAIWAN SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 532 TAIWAN CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 533 TAIWAN THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 534 TAIWAN LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 535 TAIWAN SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 536 TAIWAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 537 TAIWAN BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 538 TAIWAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 539 TAIWAN ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 540 TAIWAN SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 541 TAIWAN MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 542 TAIWAN FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 543 TAIWAN SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 544 TAIWAN MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 545 NEW ZEALAND SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 546 NEW ZEALAND NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 547 NEW ZEALAND THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 548 NEW ZEALAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 549 NEW ZEALAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 550 NEW ZEALAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 551 NEW ZEALAND ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 552 NEW ZEALAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 553 NEW ZEALAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 554 NEW ZEALAND CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 555 NEW ZEALAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 556 NEW ZEALAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 557 NEW ZEALAND ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 558 NEW ZEALAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 559 NEW ZEALAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 560 NEW ZEALAND ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 561 NEW ZEALAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 562 NEW ZEALAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 563 NEW ZEALAND NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 564 NEW ZEALAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 565 NEW ZEALAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 566 NEW ZEALAND ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 567 NEW ZEALAND OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 568 NEW ZEALAND DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 569 NEW ZEALAND DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 570 NEW ZEALAND DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 571 NEW ZEALAND SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 572 NEW ZEALAND MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 573 NEW ZEALAND SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 574 NEW ZEALAND SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 575 NEW ZEALAND CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 576 NEW ZEALAND THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 577 NEW ZEALAND LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 578 NEW ZEALAND SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 579 NEW ZEALAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 580 NEW ZEALAND BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 581 NEW ZEALAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 582 NEW ZEALAND ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 583 NEW ZEALAND SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 584 NEW ZEALAND MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 585 NEW ZEALAND FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 586 NEW ZEALAND SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 587 NEW ZEALAND MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 588 PHILIPPINES SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 589 PHILIPPINES NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 590 PHILIPPINES THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 591 PHILIPPINES REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 592 PHILIPPINES MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 593 PHILIPPINES ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 594 PHILIPPINES ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 595 PHILIPPINES ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 596 PHILIPPINES CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 597 PHILIPPINES CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 598 PHILIPPINES CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 599 PHILIPPINES ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 600 PHILIPPINES ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 601 PHILIPPINES ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 602 PHILIPPINES ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 603 PHILIPPINES ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 604 PHILIPPINES ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 605 PHILIPPINES NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 606 PHILIPPINES NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 607 PHILIPPINES NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 608 PHILIPPINES ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 609 PHILIPPINES ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 610 PHILIPPINES ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 611 PHILIPPINES OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 612 PHILIPPINES DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 613 PHILIPPINES DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 614 PHILIPPINES DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 615 PHILIPPINES SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 616 PHILIPPINES MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 617 PHILIPPINES SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 618 PHILIPPINES SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 619 PHILIPPINES CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 620 PHILIPPINES THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 621 PHILIPPINES LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 622 PHILIPPINES SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 623 PHILIPPINES MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 624 PHILIPPINES BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 625 PHILIPPINES MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 626 PHILIPPINES ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 627 PHILIPPINES SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 628 PHILIPPINES MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 629 PHILIPPINES FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 630 PHILIPPINES SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 631 PHILIPPINES MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 632 VIETNAM SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 633 VIETNAM NON-OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 634 VIETNAM THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 635 VIETNAM REHABILITATION THERAPY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 636 VIETNAM MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 637 VIETNAM ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 638 VIETNAM ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 639 VIETNAM ANTICONVULSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 640 VIETNAM CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 641 VIETNAM CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 642 VIETNAM CORTICOSTEROIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 643 VIETNAM ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 644 VIETNAM ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 645 VIETNAM ANTIDEPRESSANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 646 VIETNAM ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 647 VIETNAM ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 648 VIETNAM ANTISPASMODICS AND MUSCLE RELAXANTS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 649 VIETNAM NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 650 VIETNAM NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 651 VIETNAM NSAIDS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 652 VIETNAM ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 653 VIETNAM ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (THOUSAND UNITS)
TABLE 654 VIETNAM ANTIBIOTICS IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD/UNITS)
TABLE 655 VIETNAM OPERATIVE MANAGEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 656 VIETNAM DECOMPRESSION SURGERY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 657 VIETNAM DISC REPLACEMENT IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 658 VIETNAM DISC AND FACET JOINT REMOVAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 659 VIETNAM SPINAL FUSION IN ANTERIOR CERVICAL DISCECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 660 VIETNAM MEDIAL FACETECTOMY IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 661 VIETNAM SPINAL CORD INJURY TREATMENT MARKET, BY INJURY TYPE, 2018-2032 (USD THOUSAND)
TABLE 662 VIETNAM SPINAL CORD INJURY TREATMENT MARKET, BY LEVEL OF INJURY, 2018-2032 (USD THOUSAND)
TABLE 663 VIETNAM CERVICAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 664 VIETNAM THORACIC SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 665 VIETNAM LUMBAR SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 666 VIETNAM SACRAL SPINAL CORD INJURIES IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 667 VIETNAM MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DRUG TYPE, 2018-2032 (USD THOUSAND)
TABLE 668 VIETNAM BRANDED IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 669 VIETNAM MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 670 VIETNAM ORAL IN SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 671 VIETNAM SPINAL CORD INJURY TREATMENT MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 672 VIETNAM MALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 673 VIETNAM FEMALE IN SPINAL CORD INJURY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 674 VIETNAM SPINAL CORD INJURY TREATMENT MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 675 VIETNAM MEDICATION IN SPINAL CORD INJURY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 676 REST OF ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
그림 목록
FIGURE 1 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: SEGMENTATION
FIGURE 11 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 TWO SEGMENTS COMPRISE THE ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET, BY TYPE
FIGURE 14 GROWING COLLABORATION AND EXPANDING PARTNERSHIPS IS EXPECTED TO DRIVE THE ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET GROWTH IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 15 NON-OPERATIVE MANAGEMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC SPINAL CORD INJURY TREATMENT IN THE FORECAST PERIOD OF 2025 & 2032
FIGURE 16 MARKET OVERVIEW
FIGURE 17 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, 2024
FIGURE 18 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, 2025-2032 (USD THOUSAND)
FIGURE 19 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, CAGR (2025-2032)
FIGURE 20 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, 2024
FIGURE 22 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, 2025-2032 (USD THOUSAND)
FIGURE 23 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, CAGR (2025-2032)
FIGURE 24 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY LEVEL OF INJURY, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, 2024
FIGURE 26 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, 2025-2032 (USD THOUSAND)
FIGURE 27 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, CAGR (2025-2032)
FIGURE 28 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY INJURY TYPE, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, 2024
FIGURE 30 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, 2025-2032 (USD THOUSAND)
FIGURE 31 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, CAGR (2025-2032)
FIGURE 32 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY GENDER, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY END USER, 2024
FIGURE 34 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY END USER, 2025-2032 (USD THOUSAND)
FIGURE 35 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY END USER, CAGR (2025-2032)
FIGURE 36 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: SNAPSHOT (2024)
FIGURE 38 ASIA-PACIFIC SPINAL CORD INJURY TREATMENT MARKET: COMPANY SHARE 2024 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
